Summary

Market Overview
The Global Glaucoma Therapeutics Market , valued at USD 7.33 Billion in 2024, is projected to experience a CAGR of 6.57% to reach USD 10.74 Billion by 2030. The global glaucoma therapeutics market encompasses pharmacological and surgical interventions designed to reduce intraocular pressure and prevent optic nerve damage, thereby preserving vision in individuals diagnosed with glaucoma. Key drivers supporting market growth include the rising global prevalence of glaucoma and the expanding geriatric population.
Key Market Drivers
The increasing global geriatric population represents a fundamental demographic shift significantly influencing the glaucoma therapeutics market. As individuals age, their susceptibility to developing glaucoma rises substantially, making this demographic expansion a primary driver of increased patient volumes. Older age is a well-established risk factor for glaucoma onset and progression, directly translating to a greater need for diagnostic screenings and subsequent therapeutic interventions.
Key Market Challenges
Patient non-adherence to long-term medication regimens presents a substantial impediment to the expansion of the global glaucoma therapeutics market. The efficacy of pharmacological interventions for glaucoma is fundamentally dependent on consistent and timely patient compliance to effectively reduce intraocular pressure and avert progressive optic nerve damage. When individuals do not adhere to their prescribed treatment schedules, the disease often progresses unchecked, leading to a greater need for more advanced and often expensive surgical procedures or a shift to alternative, more complex drug therapies. This undermines the overall perceived value and effectiveness of current pharmaceutical offerings and disrupts the consistent demand for long-term medication supplies.
Key Market Trends
The integration of artificial intelligence in glaucoma diagnostics and management represents a transformative trend, enhancing the precision and efficiency of patient care. AI algorithms can analyze complex ophthalmic imaging and clinical data to facilitate earlier disease detection and more accurate progression monitoring, thereby enabling timely interventions.
Key Market Players
• Novartis AG
• Merck & Co., Inc.
• AbbVie, Inc.
• Bausch Health Companies, Inc.
• Teva Pharmaceutical Industries Ltd.
• Pfizer Inc.
• Alcon, Inc.
• Inotek Pharmaceuticals Corporation
Report Scope:
In this report, the Global Glaucoma Therapeutics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
• Glaucoma Therapeutics Market , By Treatment Type:
o Eye drops
o Medication
o Laser Surgery
o Traditional Surgery
• Glaucoma Therapeutics Market , By Glaucoma Type:
o Open angle
o Closed angle
• Glaucoma Therapeutics Market , By Region:
o North America
§ United States
§ Canada
§ Mexico
o Europe
§ France
§ United Kingdom
§ Italy
§ Germany
§ Spain
o Asia Pacific
§ China
§ India
§ Japan
§ Australia
§ South Korea
o South America
§ Brazil
§ Argentina
§ Colombia
o Middle East & Africa
§ South Africa
§ Saudi Arabia
§ UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Glaucoma Therapeutics Market .
Available Customizations:
Global Glaucoma Therapeutics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Glaucoma Therapeutics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Treatment Type (Eye drops, Medication, Laser Surgery, Traditional Surgery)
5.2.2. By Glaucoma Type (Open angle, Closed angle)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Market Map
6. North America Glaucoma Therapeutics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Treatment Type
6.2.2. By Glaucoma Type
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Glaucoma Therapeutics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Treatment Type
6.3.1.2.2. By Glaucoma Type
6.3.2. Canada Glaucoma Therapeutics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Treatment Type
6.3.2.2.2. By Glaucoma Type
6.3.3. Mexico Glaucoma Therapeutics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Treatment Type
6.3.3.2.2. By Glaucoma Type
7. Europe Glaucoma Therapeutics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Treatment Type
7.2.2. By Glaucoma Type
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Glaucoma Therapeutics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Treatment Type
7.3.1.2.2. By Glaucoma Type
7.3.2. France Glaucoma Therapeutics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Treatment Type
7.3.2.2.2. By Glaucoma Type
7.3.3. United Kingdom Glaucoma Therapeutics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Treatment Type
7.3.3.2.2. By Glaucoma Type
7.3.4. Italy Glaucoma Therapeutics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Treatment Type
7.3.4.2.2. By Glaucoma Type
7.3.5. Spain Glaucoma Therapeutics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Treatment Type
7.3.5.2.2. By Glaucoma Type
8. Asia Pacific Glaucoma Therapeutics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Treatment Type
8.2.2. By Glaucoma Type
8.2.3. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Glaucoma Therapeutics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Treatment Type
8.3.1.2.2. By Glaucoma Type
8.3.2. India Glaucoma Therapeutics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Treatment Type
8.3.2.2.2. By Glaucoma Type
8.3.3. Japan Glaucoma Therapeutics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Treatment Type
8.3.3.2.2. By Glaucoma Type
8.3.4. South Korea Glaucoma Therapeutics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Treatment Type
8.3.4.2.2. By Glaucoma Type
8.3.5. Australia Glaucoma Therapeutics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Treatment Type
8.3.5.2.2. By Glaucoma Type
9. Middle East & Africa Glaucoma Therapeutics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Treatment Type
9.2.2. By Glaucoma Type
9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Glaucoma Therapeutics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Treatment Type
9.3.1.2.2. By Glaucoma Type
9.3.2. UAE Glaucoma Therapeutics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Treatment Type
9.3.2.2.2. By Glaucoma Type
9.3.3. South Africa Glaucoma Therapeutics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Treatment Type
9.3.3.2.2. By Glaucoma Type
10. South America Glaucoma Therapeutics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Treatment Type
10.2.2. By Glaucoma Type
10.2.3. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Glaucoma Therapeutics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Treatment Type
10.3.1.2.2. By Glaucoma Type
10.3.2. Colombia Glaucoma Therapeutics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Treatment Type
10.3.2.2.2. By Glaucoma Type
10.3.3. Argentina Glaucoma Therapeutics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Treatment Type
10.3.3.2.2. By Glaucoma Type
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Glaucoma Therapeutics Market : SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Novartis AG
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Merck & Co., Inc.
15.3. AbbVie, Inc.
15.4. Bausch Health Companies, Inc.
15.5. Teva Pharmaceutical Industries Ltd.
15.6. Pfizer Inc.
15.7. Alcon, Inc.
15.8. Inotek Pharmaceuticals Corporation
16. Strategic Recommendations
17. About Us & Disclaimer